SREBF1 and metabolic dysfunction-associated steatotic liver disease: It has been showed that the lipogenic key enzymes, such as FASN, acetyl-CoA carboxylase (ACC), SREBP1c, and CD36, were increased in NAFLD animal models and patients with NAFLD [38].